Literature DB >> 19941988

Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10.

Akram A Da'dara1, Donald A Harn.   

Abstract

HIV-1 prevalence is highest in developing countries; similarly helminth parasites are often highly endemic in these same areas. Helminths are strong immune modulators, and negatively impact the ability of the infected hosts to mount protective vaccine-specific T cell immune responses for HIV-1 and other pathogens. Indeed, previously we found that Schistosoma mansoni infected mice had significantly impaired HIV-1C vaccine-specific T cell responses. Anthelminthics are available and inexpensive; therefore, in this study, we evaluated whether elimination of schistosome infection prior to vaccination with an HIV-1C DNA vaccine would increase recipients vaccine-specific responses. As expected, splenocytes from S. mansoni infected mice produced significantly elevated amounts of interleukin (IL)-4 and IL-10, and significantly lower amounts of interferon (IFN)-gamma than splenocytes from naïve mice. Following elimination of parasites by praziquantel (PZQ) treatment, splenomegaly was significantly reduced, though splenocytes produced similar or higher levels of IL-10 than splenocytes from infected mice. However, we found that PZQ treatment significantly increased levels of IFN-gamma in response to concanavalin A or SEA compared to splenocytes from untreated mice. Importantly, PZQ treatment resulted in complete restoration of HIV-1C vaccine-specific T cell responses at 8 weeks post-PZQ treatment. Restoration of HIV-1C vaccine-specific T cell responses following elimination of helminth infection was time dependent, but surprisingly independent of the levels of IL-4 and IL-10 induced by parasite antigens. Our study shows that elimination of worms offers an affordable and a simple means to restore immune responsiveness to T cell based vaccines for HIV-1 and other infectious diseases in helminth endemic settings. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941988      PMCID: PMC2831209          DOI: 10.1016/j.vaccine.2009.11.019

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  57 in total

Review 1.  Post-step modifications for research on HIV vaccines.

Authors:  Lawrence Corey; M Juliana McElrath; James G Kublin
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

2.  Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay.

Authors:  Nicola Winstone; Ana Guimarães-Walker; Joanna Roberts; Denise Brown; Vanessa Loach; Nilu Goonetilleke; Tomás Hanke; Andrew J McMichael
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

3.  Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.

Authors:  Daniel Elias; Sven Britton; Abraham Aseffa; Howard Engers; Hannah Akuffo
Journal:  Vaccine       Date:  2008-05-21       Impact factor: 3.641

4.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

5.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Authors:  John W Shiver; Tong-Ming Fu; Ling Chen; Danilo R Casimiro; Mary-Ellen Davies; Robert K Evans; Zhi-Qiang Zhang; Adam J Simon; Wendy L Trigona; Sheri A Dubey; Lingyi Huang; Virginia A Harris; Romnie S Long; Xiaoping Liang; Larry Handt; William A Schleif; Lan Zhu; Daniel C Freed; Natasha V Persaud; Liming Guan; Kara S Punt; Aimin Tang; Minchun Chen; Keith A Wilson; Kelly B Collins; Gwendolyn J Heidecker; V Rose Fernandez; Helen C Perry; Joseph G Joyce; Karen M Grimm; James C Cook; Paul M Keller; Denise S Kresock; Henryk Mach; Robert D Troutman; Lynne A Isopi; Donna M Williams; Zheng Xu; Kathryn E Bohannon; David B Volkin; David C Montefiori; Ayako Miura; Georgia R Krivulka; Michelle A Lifton; Marcelo J Kuroda; Jörn E Schmitz; Norman L Letvin; Michael J Caulfield; Andrew J Bett; Rima Youil; David C Kaslow; Emilio A Emini
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

6.  Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice.

Authors:  Akram A Da'Dara; Norman Lautsch; Timothy Dudek; Vladimir Novitsky; Tun-Hou Lee; Myron Essex; Donald A Harn
Journal:  Vaccine       Date:  2006-04-18       Impact factor: 3.641

Review 7.  Immune biasing by helminth glycans.

Authors:  Paul G Thomas; Donald A Harn
Journal:  Cell Microbiol       Date:  2004-01       Impact factor: 3.715

8.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

Review 9.  Th2 response polarization during infection with the helminth parasite Schistosoma mansoni.

Authors:  Edward J Pearce; Colleen M Kane; Jie Sun; Justin J Taylor; Amy S McKee; Laura Cervi
Journal:  Immunol Rev       Date:  2004-10       Impact factor: 12.988

10.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  17 in total

Review 1.  Cofactors that may influence vaccine responses.

Authors:  Guy de Bruyn
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

Review 2.  Developing vaccines to combat hookworm infection and intestinal schistosomiasis.

Authors:  Peter J Hotez; Jeffrey M Bethony; David J Diemert; Mark Pearson; Alex Loukas
Journal:  Nat Rev Microbiol       Date:  2010-11       Impact factor: 60.633

3.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

4.  Assessing the WHO 50% prevalence threshold in school-aged children as indication for treatment of urogenital schistosomiasis in adults in central Nigeria.

Authors:  Darin S Evans; Jonathan D King; Abel Eigege; John Umaru; William Adamani; Kal Alphonsus; Yohanna Sambo; Emmanual S Miri; Danjuma Goshit; Gladys Ogah; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

5.  Schistosoma mansoni infection induces plasmablast and plasma cell death in the bone marrow and accelerates the decline of host vaccine responses.

Authors:  Fungai Musaigwa; Severin Donald Kamdem; Thabo Mpotje; Paballo Mosala; Nada Abdel Aziz; De'Broski R Herbert; Frank Brombacher; Justin Komguep Nono
Journal:  PLoS Pathog       Date:  2022-02-14       Impact factor: 6.823

Review 6.  The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game.

Authors:  Paul Ogongo; Ruth K Nyakundi; Gerald K Chege; Lucy Ochola
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

7.  Schistosoma mansoni soluble egg antigens enhance Listeria monocytogenes vector HIV-1 vaccine induction of cytotoxic T cells.

Authors:  Cac T Bui; Lisa M Shollenberger; Yvonne Paterson; Donald A Harn
Journal:  Clin Vaccine Immunol       Date:  2014-07-02

Review 8.  Translatability of helminth therapy in inflammatory bowel diseases.

Authors:  Joel V Weinstock; David E Elliott
Journal:  Int J Parasitol       Date:  2012-11-21       Impact factor: 3.981

Review 9.  Modulation of specific and allergy-related immune responses by helminths.

Authors:  Emilia Daniłowicz-Luebert; Noëlle L O'Regan; Svenja Steinfelder; Susanne Hartmann
Journal:  J Biomed Biotechnol       Date:  2011-12-15

10.  Integration of deworming into HIV care and treatment: a neglected opportunity.

Authors:  Helen L Gerns; Laura R Sangaré; Judd L Walson
Journal:  PLoS Negl Trop Dis       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.